CL vs. EMR
CL (Colgate-Palmolive Company) and EMR (Emerson Electric Co.) are both stocks. CL operates in Household & Personal Products (Consumer Defensive), while EMR operates in Specialty Industrial Machinery (Industrials). Over the past 10 years, CL returned 4.14%/yr vs 13.21%/yr for EMR. At a 0.29 correlation, their price movements are largely independent.
Performance
CL vs. EMR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CL achieves a 8.73% return, which is significantly higher than EMR's 6.99% return. Over the past 10 years, CL has underperformed EMR with an annualized return of 4.14%, while EMR has yielded a comparatively higher 13.21% annualized return.
CL
- 1D
- -3.85%
- 1M
- -0.59%
- YTD
- 8.73%
- 6M
- 9.87%
- 1Y
- -3.98%
- 3Y*
- 6.21%
- 5Y*
- 2.62%
- 10Y*
- 4.14%
EMR
- 1D
- -0.81%
- 1M
- 4.42%
- YTD
- 6.99%
- 6M
- 5.27%
- 1Y
- 18.92%
- 3Y*
- 21.58%
- 5Y*
- 9.66%
- 10Y*
- 13.21%
CL vs. EMR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CL Colgate-Palmolive Company | 8.73% | -10.98% | 16.57% | 3.78% | -5.44% | 2.08% | 27.17% | 18.60% | -19.19% | 17.88% |
EMR Emerson Electric Co. | 6.99% | 8.92% | 29.73% | 3.75% | 5.74% | 18.19% | 8.61% | 31.53% | -11.87% | 29.05% |
Correlation
The correlation between CL and EMR is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 1977 | 0.29 |
Over the past year, the correlation between CL and EMR has dropped to 0.05 - well below their long-term average of 0.29, suggesting their price drivers have been diverging.
Fundamentals
CL:
$68.33B
EMR:
$79.32B
CL:
$2.58
EMR:
$4.33
CL:
32.90
EMR:
32.52
CL:
8.50
EMR:
11.56
CL:
3.30
EMR:
4.34
CL:
471.23
EMR:
3.90
CL:
$20.80B
EMR:
$18.32B
CL:
$12.49B
EMR:
$7.22B
CL:
$3.92B
EMR:
$3.87B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CL vs. EMR — Risk / Return Rank
CL
EMR
CL vs. EMR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Colgate-Palmolive Company (CL) and Emerson Electric Co. (EMR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CL | EMR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.83 | ||
| Sortino ratioReturn per unit of downside risk | -1.19 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.13 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.21 | 0.81 | -1.02 |
| Martin ratioReturn relative to average drawdown | -0.36 | 1.79 | -2.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CL | EMR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.19 | 0.64 | -0.83 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | 0.36 | -0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.21 | 0.46 | -0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.34 | +0.08 |
Drawdowns
CL vs. EMR - Drawdown Comparison
The maximum CL drawdown since its inception was -58.91%, roughly equal to the maximum EMR drawdown of -59.05%. Use the drawdown chart below to compare losses from any high point for CL and EMR.
Loading charts...
Drawdown Indicators
| CL | EMR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.91% | -59.05% | +0.14% |
Max Drawdown (1Y)Largest decline over 1 year | -18.64% | -23.45% | +4.81% |
Max Drawdown (3Y)Largest decline over 3 years | -29.05% | -29.62% | +0.57% |
Max Drawdown (5Y)Largest decline over 5 years | -29.05% | -29.62% | +0.57% |
Max Drawdown (10Y)Largest decline over 10 years | -29.05% | -50.77% | +21.72% |
Current DrawdownCurrent decline from peak | -18.69% | -12.18% | -6.51% |
Average DrawdownAverage peak-to-trough decline | -11.24% | -14.11% | +2.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.21% | 10.59% | +0.62% |
Volatility
CL vs. EMR - Volatility Comparison
The current volatility for Colgate-Palmolive Company (CL) is 6.45%, while Emerson Electric Co. (EMR) has a volatility of 10.89%. This indicates that CL experiences smaller price fluctuations and is considered to be less risky than EMR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CL | EMR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.45% | 10.89% | -4.44% |
Volatility (6M)Calculated over the trailing 6-month period | 16.66% | 24.58% | -7.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.10% | 29.89% | -8.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.64% | 27.22% | -8.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.67% | 29.09% | -9.42% |
Dividends
CL vs. EMR - Dividend Comparison
CL's dividend yield for the trailing twelve months is around 2.46%, more than EMR's 1.56% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CL Colgate-Palmolive Company | 2.46% | 2.61% | 2.18% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% |
EMR Emerson Electric Co. | 1.56% | 1.61% | 1.70% | 2.14% | 2.15% | 2.18% | 2.49% | 2.58% | 3.26% | 2.76% | 3.42% | 3.94% |
Financials
CL vs. EMR - Financials Comparison
This section allows you to compare key financial metrics between Colgate-Palmolive Company and Emerson Electric Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CL vs. EMR - Profitability Comparison
CL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Colgate-Palmolive Company reported a gross profit of 3.23B and revenue of 5.32B. Therefore, the gross margin over that period was 60.6%.
EMR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Emerson Electric Co. reported a gross profit of 0.00 and revenue of 4.56B. Therefore, the gross margin over that period was 0.0%.
CL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Colgate-Palmolive Company reported an operating income of 1.16B and revenue of 5.32B, resulting in an operating margin of 21.7%.
EMR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Emerson Electric Co. reported an operating income of 0.00 and revenue of 4.56B, resulting in an operating margin of 0.0%.
CL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Colgate-Palmolive Company reported a net income of 646.00M and revenue of 5.32B, resulting in a net margin of 12.1%.
EMR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Emerson Electric Co. reported a net income of 618.00M and revenue of 4.56B, resulting in a net margin of 13.6%.
Frequently Asked Questions
CL and EMR have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EMR has higher volatility (10.89%) compared to CL (6.45%). In terms of maximum drawdown, CL dropped -58.91% vs EMR's -59.05%.
EMR currently has the higher Sharpe Ratio (0.64 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CL and EMR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer